Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pathology|September 13, 2022
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodiesMassimo Radin, Alice Barinotti, Irene Cecchi, et al.
Immunologic Research|July 10, 2021
Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodiesMassimo Radin, Alice Barinotti, Silvia Grazietta Foddai, et al.
Clinical and Experimental Rheumatology|November 17, 2020
The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomesKaren Schreiber, Massimo Radin, Irene Cecchi, et al.
International Journal of Molecular Sciences|December 18, 2020
Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome SequencingAlice Barinotti, Massimo Radin, Irene Cecchi, et al.
Immunologic Research|March 8, 2024
Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping reviewSavino Sciascia, Silvia Grazietta Foddai, Marta Arbrile, et al.
Lupus|November 2, 2023
Thrombosis and APS: Lessons Learned from Another Black Swan TaleSofia Camerlo, Irene Cecchi, Silvia Grazietta Foddai, et al.
Thrombosis and Haemostasis|March 19, 2020
Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid SyndromeMassimo Radin, Silvia G Foddai, Irene Cecchi, et al.
Journal of Autoimmunity|January 1, 2026
Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case studyDario Roccatello, Alice Barinotti, Massimo Radin, et al.
Thrombosis Research|November 26, 2025
Thrombocytopenia in antiphospholipid syndrome: predictors, prognostic implications, and thrombotic risk in a large cohort studyDavid Galarza, Massimo Radin, Irene Cecchi, et al.
Pageof 8